Functional improvement and biological variations with sacubitril-valsartan and dapaglifozine prescription in the elderly with chronic heart failure. 350 patients, 85 and over, 3 years follow-up - Université de La Réunion Accéder directement au contenu
Article Dans Une Revue Archives of Cardiovascular Diseases Supplements Année : 2022

Functional improvement and biological variations with sacubitril-valsartan and dapaglifozine prescription in the elderly with chronic heart failure. 350 patients, 85 and over, 3 years follow-up

Dates et versions

hal-04540837 , version 1 (10-04-2024)

Identifiants

Citer

S. Destrac, Maxime Cournot, M. Galinier. Functional improvement and biological variations with sacubitril-valsartan and dapaglifozine prescription in the elderly with chronic heart failure. 350 patients, 85 and over, 3 years follow-up. Archives of Cardiovascular Diseases Supplements, 2022, 14 (1), pp.32-33. ⟨10.1016/j.acvdsp.2021.09.072⟩. ⟨hal-04540837⟩
3 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More